Certified by Founder
Lodge
Edgewood Oncology
start up
United States
- Boston, Massachusetts
- 26/03/2024
- Series A
- $20,000,000
Synergistically targeting the master regulators of cancer
- Industry Biotechnology Research
- Website https://www.edgewoodoncology.com/
- LinkedIn https://www.linkedin.com/company/edgewood-oncology/
Related People
David CookFounder
United States -
Boston, Massachusetts
Accomplished senior executive and developer of biotechnology products. Experienced with microbiome therapeutics, vaccines, small molecules, and biologics. Involved in all aspects of product development including discovery research, clinical trials, regulatory affairs, manufacturing, business development, intellectual property and corporate operations. Directly responsible for obtaining the EU marketing authorization for four novel medical products.
Specialties: Microbiome, Infectious Disease, Vaccines and Immunotherapy, Inflammation and Immunology, Immuno-oncology
Tribe Stays | $2,800,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)
PowerLattice | $25,000,000 | (Nov 18, 2025)
Shipday | $7,000,000 | (Nov 18, 2025)
Muse Software | $4,500,000 | (Nov 18, 2025)
Artios | $115,000,000 | (Nov 18, 2025)
Scripta Therapeutics | $12,000,000 | (Nov 18, 2025)
Self Labs | $9,000,000 | (Nov 18, 2025)
Obello | $8,500,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
Skeletalis, Inc. | $8,000,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)